检索结果 - David Cosgrove

Refine Results
  1. 1
    Management of perihilar cholangiocarcinoma in the era of multimodal therapy

    Management of perihilar cholangiocarcinoma in the era of multimodal therapy 由 Vicente Valero, David Cosgrove, Joseph M. Herman, Timothy M. Pawlik

    出版 2012
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Pattern of distant metastases in colorectal cancer: a SEER based study

    Pattern of distant metastases in colorectal cancer: a SEER based study 由 Miao‐Zhen Qiu, Jian-Ming Hu, Dajun Yang, David Cosgrove, Rui‐Hua Xu

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma

    Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma 由 Timothy M. Pawlik, Diane K. Reyes, David Cosgrove, Ihab R. Kamel, Nikhil Bhagat, Jean-François H. Geschwind

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management

    Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management 由 Kelly J. Lafaro, David Cosgrove, Jean-François H. Geschwind, Ihab R. Kamel, Joseph M. Herman, Timothy M. Pawlik

    出版 2015
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Infiltrating Hepatocellular Carcinoma: Seeing the Tree through the Forest

    Infiltrating Hepatocellular Carcinoma: Seeing the Tree through the Forest 由 Aram N. Demirjian, Peter D. Peng, Jean-François H. Geschwind, David Cosgrove, Jacob Schutz, Ihab R. Kamel, Timothy M. Pawlik

    出版 2011
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Emerging Approaches in the Management of Patients with Neuroendocrine Liver Metastasis: Role of Liver-Directed and Systemic Therapies

    Emerging Approaches in the Management of Patients with Neuroendocrine Liver Metastasis: Role of Liver-Directed and Systemic Therapies 由 Skye C. Mayo, Joseph M. Herman, David Cosgrove, Nik Bhagat, Ihab R. Kamel, Jean-François H. Geschwind, Timothy M. Pawlik

    出版 2012
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  7. 7
    Referral Patterns and Treatment Choices for Patients with Hepatocellular Carcinoma: A United States Population-Based Study

    Referral Patterns and Treatment Choices for Patients with Hepatocellular Carcinoma: A United States Population-Based Study 由 Omar Hyder, Rebecca M. Dodson, Hari Nathan, Joseph M. Herman, David Cosgrove, Ihab R. Kamel, Jean-François H. Geschwind, Timothy M. Pawlik

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma: A National Perspective

    Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma: A National Perspective 由 Skye C. Mayo, Michael N. Mavros, Hari Nathan, David Cosgrove, Joseph M. Herman, Ihab R. Kamel, Robert A. Anders, Timothy M. Pawlik

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Association Between Specific Mutations in<i>KRAS</i>Codon 12 and Colorectal Liver Metastasis

    Association Between Specific Mutations in<i>KRAS</i>Codon 12 and Colorectal Liver Metastasis 由 Georgios Antonios Margonis, Yuhree Kim, Gaya Spolverato, Aslam Ejaz, Rohan Gupta, David Cosgrove, Robert A. Anders, Georgios Karagkounis, Michael A. Choti, Timothy M. Pawlik

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours

    Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours 由 Devalingam Mahalingam, George Wilding, Samuel R. Denmeade, J. Sarantopoulas, David Cosgrove, Jeremy Cetnar, Nilofer S. Azad, Justine Y. Bruce, Michael R. Kurman, Victoria Allgood, Michael A. Carducci

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network

    Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network 由 David Cosgrove, Ruoding Tan, Andrew J. Osterland, Sairy Hernandez, Sarika Ogale, Sami Mahrus, John Murphy, Thomas W. Wilson, Gregory Patton, Arturo Loaiza‐Bonilla, Amit G. Singal

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Impact of Sarcopenia on Outcomes Following Intra-arterial Therapy of Hepatic Malignancies

    Impact of Sarcopenia on Outcomes Following Intra-arterial Therapy of Hepatic Malignancies 由 Rebecca M. Dodson, Amin Firoozmand, Omar Hyder, Vania Tacher, David Cosgrove, Nikhil Bhagat, Joseph M. Herman, Christopher L. Wolfgang, Jean-François H. Geschwind, Ihab R. Kamel, Timothy M. Pawlik

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Impact of a Single-Day Multidisciplinary Clinic on the Management of Patients with Liver Tumours

    Impact of a Single-Day Multidisciplinary Clinic on the Management of Patients with Liver Tumours 由 Jiangyang Zhang, Michail N. Mavros, David Cosgrove, Kenzo Hirose, Joseph M. Herman, S. Smallwood–Massey, Ihab R. Kamel, Ahmet Gürakar, Robert A. Anders, Andrew M. Cameron, J. Geschwind, Timothy M. Pawlik

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features

    Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features 由 Laura D. Wood, Christopher M. Heaphy, Hubert Darius-J Daniel, Bita V. Naini, Charles Lassman, May R. Arroyo, Ihab R. Kamel, David Cosgrove, John K. Boitnott, Alan K. Meeker, Michael Torbenson

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Neuroendocrine Liver Metastasis Treated by Using Intraarterial Therapy: Volumetric Functional Imaging Biomarkers of Early Tumor Response and Survival

    Neuroendocrine Liver Metastasis Treated by Using Intraarterial Therapy: Volumetric Functional Imaging Biomarkers of Early Tumor Response and Survival 由 Vivek Gowdra Halappa, Celia P. Corona‐Villalobos, Susanne Bonekamp, Zhen Li, Diane K. Reyes, David Cosgrove, Timothy M. Pawlik, Luis A. Díaz, Nikhil Bhagat, John Eng, Jean-François H. Geschwind, Ihab R. Kamel

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

    Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors 由 Edward A. Sausville, Patricia LoRusso, Michael A. Carducci, Judith Carter, Mary Flanagan Quinn, Lisa Malburg, Nilofer S. Azad, David Cosgrove, Richard Knight, Peter Barker, Sonya Zabludoff, Felix Agbo, Patricia Oakes, Adrian M. Senderowicz

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours

    A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours 由 Breelyn A. Wilky, Michelle A. Rudek, Shabina Roohi Ahmed, Dan Laheru, David Cosgrove, Ross C. Donehower, Barry D. Nelkin, Douglas W. Ball, L. Austin Doyle, H Chen, X Ye, Graham Bigley, Chris Womack, Nilofer S. Azad

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial

    TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Live... 由 Nikhil Chauhan, Mary F. Mulcahy, Riad Salem, Al B. Benson, Éveline Boucher, Janet Bukovcan, David Cosgrove, Chantal Laframboise, Robert J. Lewandowski, Fayaz Master, Bassel F. El‐Rayes, Jonathan Strosberg, Daniel Y. Sze, Ricky A. Sharma

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Diffuse Infiltrative Hepatocellular Carcinoma: Assessment of Presentation, Treatment, and Outcomes

    Diffuse Infiltrative Hepatocellular Carcinoma: Assessment of Presentation, Treatment, and Outcomes 由 Peter J. Kneuertz, Aram N. Demirjian, Amin Firoozmand, Celia P. Corona‐Villalobos, Nikhil Bhagat, Joseph M. Herman, Andrew M. Cameron, Ahmet Gürakar, David Cosgrove, Michael A. Choti, Jean-François H. Geschwind, Ihab R. Kamel, Timothy M. Pawlik

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations

    Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations 由 Josh Lauring, David Cosgrove, Stefani C. Fontana, John P. Gustin, Hiroyuki Konishi, Abde M. Abukhdeir, Joseph P. Garay, Morassa Mohseni, Guoli Wang, Michaela J. Higgins, David U. Gorkin, Marcelo Reis, Bert Vogelstein, Kornélia Polyák, Marianne Cowherd, Phillip Buckhaults, B H Park

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: